Protocol to request
Prophylactic efficacy studies of 2H5, 2H5-A14 and 2H5-A14-DANA mutant against HDV infection in mouse models with humanized NTCP.
Research article
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Dan Li et al.
DOI: 10.7554/eLife.26738